Filtered By:
Drug: Amitriptyline
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 68 results found since Jan 2013.
Clinical Characteristics and Medication Uses Among Fibromyalgia Patients Newly Prescribed Amitriptyline, Duloxetine, Gabapentin, or Pregabalin
ConclusionPatients who started 1 of the 4 common drugs for fibromyalgia similarly had multiple comorbidities and other fibromyalgia‐related medication use, but continued the treatment only for a short time. The dose of the 4 drugs was not increased in most patients during the followup period.
Source: Arthritis Care and Research - October 28, 2013 Category: Rheumatology Authors: Seoyoung C. Kim, Joan E. Landon, Daniel H. Solomon Tags: Fibromyalgia Source Type: research
Amitriptyline for fibromyalgia in adults.
CONCLUSIONS: Amitriptyline has been a first-line treatment for fibromyalgia for many years. The fact that there is no supportive unbiased evidence for a beneficial effect is disappointing, but has to be balanced against years of successful treatment in many patients with fibromyalgia. There is no good evidence of a lack of effect; rather our concern should be of overestimation of treatment effect. Amitriptyline will be one option in the treatment of fibromyalgia, while recognising that only a minority of patients will achieve satisfactory pain relief.It is unlikely that any large randomised trials of amitriptyline will be ...
Source: Cochrane Database of Systematic Reviews - August 3, 2015 Category: Journals (General) Authors: Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ Tags: Cochrane Database Syst Rev Source Type: research
Antipsychotics for fibromyalgia in adults.
CONCLUSIONS: Very low quality evidence suggests that quetiapine may be considered for a time-limited trial (4 to 12 weeks) to reduce pain, sleep problems, depression and anxiety in fibromyalgia patients with major depression. Potential side effects such as weight gain should be balanced against the potential benefits in shared decision making with the patient.
PMID: 27251337 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - June 1, 2016 Category: Journals (General) Authors: Walitt B, Klose P, Üçeyler N, Phillips T, Häuser W Tags: Cochrane Database Syst Rev Source Type: research
Cannabinoids for fibromyalgia.
CONCLUSIONS: We found no convincing, unbiased, high quality evidence suggesting that nabilone is of value in treating people with fibromyalgia. The tolerability of nabilone was low in people with fibromyalgia.
PMID: 27428009 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - July 17, 2016 Category: Journals (General) Authors: Walitt B, Klose P, Fitzcharles MA, Phillips T, Häuser W Tags: Cochrane Database Syst Rev Source Type: research
Fibromyalgia: Diagnosis and Management
Am Fam Physician. 2023 Feb;107(2):137-144.ABSTRACTFibromyalgia is a chronic, centralized pain syndrome characterized by disordered processing of painful stimuli. Fibromyalgia is diagnosed more frequently in women and occurs globally, affecting 2% of people in the United States. Patients with fibromyalgia have diffuse chronic pain, poor sleep, fatigue, cognitive dysfunction, and mood disturbances. Comorbid conditions, such as functional somatic syndromes, psychiatric diagnoses, and rheumatologic conditions may be present. The Fibromyalgia Rapid Screening Tool is a helpful screening method for patients with diffuse chronic p...
Source: American Family Physician - February 15, 2023 Category: Primary Care Authors: Bradford T Winslow Carmen Vandal Laurel Dang Source Type: research
